Scientists at Washington State University, USA, have conducted a clinical trial to investigate the acute effect of cannabigerol on anxiety, stress, and mood in healthy individuals. They have published ...

In a recent study published in Scientific Reports, researchers conducted a placebo-controlled, double-blind crossover field trial to examine whether the phytocannabinoid cannabigerol impacted mood, ...

PORTLAND, Ore. (KOIN) – A clinical trial by researchers at Washington State University found that a lesser-known cannabinoid that’s growing in popularity can help ease anxiety without the intoxication ...

A lesser-known cannabinoid that is gaining in popularity Cannabigerol (CBG) effectively reduced anxiety in a clinical trial without the intoxication typically associated with whole plant cannabis. It ...

A lesser-known cannabinoid known as CBG has surprised scientists after a first-ever human clinical trial found that it appears to improve memory while also "significantly" reducing anxiety and stress.

The cannabidiol (CBD) market has exploded in recent years, with estimates from 2021 evaluating the global CBD market at a whopping $5.18 billion (and growing).1 The reality is that CBD has become an ...